EVE & CO INCORPORATED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1 CAD | -.--% |
|
-.--% | -.--% |
| 2022 | Eve & Co Incorporated Obtains Court Approval of Sales Process | CI |
| 2022 | Eve & Co Incorporated Primary Exchange Listing has Changed to TSX Venture Exchange - Nex from TSX Venture Exchange | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Alternative Medicine
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 26.94L | - | - | - | - | - | |
| 602.09Cr | ||||||
| 418.94Cr | ||||||
| 325.49Cr | - | - | ||||
| 287.36Cr | ||||||
| 237.49Cr | - | - | - | - | - |
